DGX vs FMS
Quest Diagnostics Inc. and Fresenius Medical Care AG, side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | DGX | FMS |
|---|---|---|
| Revenue | $11.0B | $14.6B |
| Net income | $992.0M | $1.1B |
| Gross margin | 33.2% | 32.4% |
| Net margin | 9.5% | 8.6% |
| Return on equity | 14.2% | 12.2% |
| Diluted EPS | $8.75 | $3.65 |
| Dividend / share | — | — |
| Payout ratio | 35.6% | 26.7% |
| Free cash flow | $1.4B | $1.3B |
| Equity | $7.2B | $9.2B |
| Net debt / equity | 0.73× | 0.78× |
| Current ratio | 1.04× | 1.77× |
| Revenue CAGR 5y | 3.2% | 6.6% |
| Profit CAGR 5y | −7.1% | 6.3% |
FMS bills 1.3× the revenue of DGX, and DGX keeps more of each dollar of revenue as profit (9.5% against 8.6%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
7 years side by side
| Fiscal year | DGX | FMS |
|---|---|---|
| FY2013 | $7.1B | $14.6B |
| FY2012 | $7.4B | $13.8B |
| FY2011 | $7.4B | $12.6B |
| FY2010 | $7.3B | $11.8B |
| FY2009 | $7.5B | $11.2B |
| FY2008 | $7.2B | $10.6B |
| FY2007 | $6.7B | $9.7B |
Net income by year
Bottom line
| Fiscal year | DGX | FMS |
|---|---|---|
| FY2013 | $849.0M | $1.1B |
| FY2012 | $556.0M | $1.2B |
| FY2011 | $471.0M | $1.1B |
| FY2010 | $720.9M | $978.5M |
| FY2009 | $729.1M | $891.1M |
| FY2008 | $581.5M | $817.6M |
| FY2007 | $339.9M | $717.1M |